| Douglas W Laske, MD | |
|
2510 Maryland Rd Ste 185, Willow Grove, PA 19090-1134 | |
| (215) 657-5886 | |
| (215) 657-9996 |
| Full Name | Douglas W Laske |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 39 Years |
| Location | 2510 Maryland Rd Ste 185, Willow Grove, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275521254 | NPI | - | NPPES |
| 0015165680001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD055501L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abington Memorial Hospital | Abington, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Abington Memorial Hospital | 3274437736 | 528 |
News Archive
Galderma Laboratories, L.P. today announced the U.S. Food and Drug Administration approval of Differin® (adapalene) Lotion, 0.1%, the first-ever lotion formulation of the well-tolerated retinoid adapalene, for the treatment of acne. Differin Lotion, 0.1% will be available by prescription in April 2010.
Pfizer has announced that the U.S. Food and Drug Administration has approved its cholesterol-lowering therapy Lipitor® (atorvastatin calcium) for the prevention of cardiovascular disease by reducing heart attack risk in people with normal to mildly elevated cholesterol levels who have other cardiovascular risk factors.
Achieving the secure nationwide exchange of health information and patient medical information using the Internet will be advanced by adopting existing standards, technology and currently used approaches to authenticate digital identities, according to testimony presented today to the National Health Information Network (NHIN) committee advising on the development of a nationwide health information infrastructure. The testimony was delivered by SAFE-BioPharma Association, the non-profit that developed and maintains the SAFE-BioPharma® digital identity and signature standard.
Most parents who have lost a premature baby still hold the baby in a central place in their lives two to six years after the baby's death, physicians report in a new small study.
New findings suggest that most Americans with depression receive no treatment, while raising the possibility that overtreatment of depression is also widespread.
› Verified 2 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386685386 PECOS PAC ID: 3274437736 Enrollment ID: O20031209000676 |
News Archive
Galderma Laboratories, L.P. today announced the U.S. Food and Drug Administration approval of Differin® (adapalene) Lotion, 0.1%, the first-ever lotion formulation of the well-tolerated retinoid adapalene, for the treatment of acne. Differin Lotion, 0.1% will be available by prescription in April 2010.
Pfizer has announced that the U.S. Food and Drug Administration has approved its cholesterol-lowering therapy Lipitor® (atorvastatin calcium) for the prevention of cardiovascular disease by reducing heart attack risk in people with normal to mildly elevated cholesterol levels who have other cardiovascular risk factors.
Achieving the secure nationwide exchange of health information and patient medical information using the Internet will be advanced by adopting existing standards, technology and currently used approaches to authenticate digital identities, according to testimony presented today to the National Health Information Network (NHIN) committee advising on the development of a nationwide health information infrastructure. The testimony was delivered by SAFE-BioPharma Association, the non-profit that developed and maintains the SAFE-BioPharma® digital identity and signature standard.
Most parents who have lost a premature baby still hold the baby in a central place in their lives two to six years after the baby's death, physicians report in a new small study.
New findings suggest that most Americans with depression receive no treatment, while raising the possibility that overtreatment of depression is also widespread.
› Verified 2 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861742900 PECOS PAC ID: 3274437736 Enrollment ID: O20180420001807 |
News Archive
Galderma Laboratories, L.P. today announced the U.S. Food and Drug Administration approval of Differin® (adapalene) Lotion, 0.1%, the first-ever lotion formulation of the well-tolerated retinoid adapalene, for the treatment of acne. Differin Lotion, 0.1% will be available by prescription in April 2010.
Pfizer has announced that the U.S. Food and Drug Administration has approved its cholesterol-lowering therapy Lipitor® (atorvastatin calcium) for the prevention of cardiovascular disease by reducing heart attack risk in people with normal to mildly elevated cholesterol levels who have other cardiovascular risk factors.
Achieving the secure nationwide exchange of health information and patient medical information using the Internet will be advanced by adopting existing standards, technology and currently used approaches to authenticate digital identities, according to testimony presented today to the National Health Information Network (NHIN) committee advising on the development of a nationwide health information infrastructure. The testimony was delivered by SAFE-BioPharma Association, the non-profit that developed and maintains the SAFE-BioPharma® digital identity and signature standard.
Most parents who have lost a premature baby still hold the baby in a central place in their lives two to six years after the baby's death, physicians report in a new small study.
New findings suggest that most Americans with depression receive no treatment, while raising the possibility that overtreatment of depression is also widespread.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Douglas W Laske, MD 2510 Maryland Rd Ste 185, Willow Grove, PA 19090-1134 Ph: (215) 657-5886 | Douglas W Laske, MD 2510 Maryland Rd Ste 185, Willow Grove, PA 19090-1134 Ph: (215) 657-5886 |
News Archive
Galderma Laboratories, L.P. today announced the U.S. Food and Drug Administration approval of Differin® (adapalene) Lotion, 0.1%, the first-ever lotion formulation of the well-tolerated retinoid adapalene, for the treatment of acne. Differin Lotion, 0.1% will be available by prescription in April 2010.
Pfizer has announced that the U.S. Food and Drug Administration has approved its cholesterol-lowering therapy Lipitor® (atorvastatin calcium) for the prevention of cardiovascular disease by reducing heart attack risk in people with normal to mildly elevated cholesterol levels who have other cardiovascular risk factors.
Achieving the secure nationwide exchange of health information and patient medical information using the Internet will be advanced by adopting existing standards, technology and currently used approaches to authenticate digital identities, according to testimony presented today to the National Health Information Network (NHIN) committee advising on the development of a nationwide health information infrastructure. The testimony was delivered by SAFE-BioPharma Association, the non-profit that developed and maintains the SAFE-BioPharma® digital identity and signature standard.
Most parents who have lost a premature baby still hold the baby in a central place in their lives two to six years after the baby's death, physicians report in a new small study.
New findings suggest that most Americans with depression receive no treatment, while raising the possibility that overtreatment of depression is also widespread.
› Verified 2 days ago
Dr. Jonas Joaquin Gopez, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2510 Maryland Rd, Ste185, Willow Grove, PA 19090 Phone: 215-657-5886 Fax: 215-657-5844 | |
Dr. Steven Jon Barrer, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2510 Maryland Rd, Ste 185, Willow Grove, PA 19090 Phone: 215-657-5886 Fax: 215-657-5844 | |
Dr. Michael Sungshick Yoon, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2510 Maryland Rd, Ste 185, Willow Grove, PA 19090 Phone: 215-657-5886 Fax: 215-657-9996 |